Open access
214
Views
4
CrossRef citations to date
0
Altmetric
Review
Cardiovascular Risk Reduction in Type 2 Diabetes: Therapeutic Potential of Dapagliflozin
Ioannis Avgerinos1 Clinical Research and Evidence-Based Medicine Unit, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, GreeceCorrespondence[email protected]
https://orcid.org/0000-0003-2232-1342
Aris Liakos1 Clinical Research and Evidence-Based Medicine Unit, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece;2 Diabetes Centre, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece
https://orcid.org/0000-0003-3261-2979
Apostolos Tsapas1 Clinical Research and Evidence-Based Medicine Unit, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece;2 Diabetes Centre, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece;3 Harris Manchester College, University of Oxford, Oxford, UK
https://orcid.org/0000-0003-0221-4072
Eleni Bekiari1 Clinical Research and Evidence-Based Medicine Unit, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece;2 Diabetes Centre, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece
https://orcid.org/0000-0001-9975-3835
Pages 2549-2557
|
Published online: 03 Dec 2019
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.